Abstract
Two human immunodeficiency virus-infected patients with refractory disseminated Mycobacterium avium complex infection were treated with recombinant interferon-gamma (IFN-gamma) given subcutaneously for 3 and 4 months, respectively. Although both patients demonstrated some clinical improvement initially, IFN-gamma therapy did not produce sustained benefit.
Original language | English |
---|---|
Pages (from-to) | e81-82 |
Journal | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |
Volume | 32 |
Issue number | 4 |
DOIs | |
Publication status | Published - 15 Feb 2001 |